Trial
NCT02784795
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Eli Lilly and Company
Collaborators
—
Condition
Solid Tumor
Intervention
LY3039478
Why stopped
The study was terminated due to business considerations
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-21